Pharmacological modulation of fibrinolysis by antithrombotic and cardiovascular drugs

This publication has 177 references indexed in Scilit:

• Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages
  Biochemical and Biophysical Research Communications, 1991
• Receptor-mediated generation of an EDRF-like intermediate in a neuronal cell line detected by spin trapping techniques
  Biochemical and Biophysical Research Communications, 1990
• The effects of dietary marine fish oils (omega-3 fatty acids) on coagulation profiles in men
  General Pharmacology: The Vascular System, 1990
• Thrombolytic Activity of Defibrotide Against Old Venous Thrombi
  Seminars in Thrombosis and Hemostasis, 1989
• Treatment of Acute Myocardial Infarction with Defibrotide
  Seminars in Thrombosis and Hemostasis, 1989
• Thrombectomy, Lysis, or Heparin Treatment: Concurrent Therapies of Deep Vein Thrombosis: Therapy and Experimental Studies
  Seminars in Thrombosis and Hemostasis, 1989
• Evidence for two platelet activating factor receptors on eosinophils: Dissociation between PAF-induced intracellular calcium mobilization degranulation and superoxides anion generation in eosinophils
  Biochemical and Biophysical Research Communications, 1989
• Inhibition of Tissue Plasminogen Activator Inhibitor by Defibrotide in Atherosclerotic Patients
  Seminars in Thrombosis and Hemostasis, 1989
• Cryptolepine inhibits platelet aggregation in vitro and in vivo and stimulates fibrinolysis ex vivo
  General Pharmacology: The Vascular System, 1988
• Thrombolytic Therapy
  New England Journal of Medicine, 1984